Key Theme: Dialogue Between Chinese and Foreign Experts – New Advances in Research on β-Blockers

The eighth session of the 2026 Asian Cardiovascular Disease Series of Web Seminars is scheduled to take place on August 26, 2026, from 19:00 to 20:30 Beijing Time (13:00-14:30 CEST). Centered on the theme "Dialogue Between Chinese and Foreign Experts - New Advances in Research on β-Blockers," this virtual event will be hosted by Prof. Xiangqing Kong (CN), uniting leading experts from China and Europe for a stimulating scientific conversation.

The proceedings will begin with introductory remarks from Prof. Xiangqing Kong (CN), leading into two plenary addresses: Prof. Nikola Bulj (HR) will speak on "Beta-Blockers in 2026: An Update?," and Prof. Xiaoguang Yao (CN) will delve into "Evidence-Based Benefits of Beta-Blockers in the Standardized Treatment of Coronary Artery Disease." A lively panel discussion, moderated by Prof. Jincun Guo (CN) and Prof. Huanji Zhang (CN), will allow for a thorough exploration of practical considerations surrounding beta-blocker use in contemporary CAD care. The session will close with a wrap-up by Prof. Xiangqing Kong (CN), underscoring the core messages from this transnational exchange.

Click here or Scan the QR code to access this informative session. We intend to equip participants with actionable insights and drive forward progress in cardiovascular medicine, with a particular focus on translating current evidence into daily clinical decision-making.